1. Home
  2. FET vs ADAP Comparison

FET vs ADAP Comparison

Compare FET & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FET
  • ADAP
  • Stock Information
  • Founded
  • FET 2005
  • ADAP 2008
  • Country
  • FET United States
  • ADAP United Kingdom
  • Employees
  • FET N/A
  • ADAP N/A
  • Industry
  • FET Metal Fabrications
  • ADAP Biotechnology: Pharmaceutical Preparations
  • Sector
  • FET Industrials
  • ADAP Health Care
  • Exchange
  • FET Nasdaq
  • ADAP Nasdaq
  • Market Cap
  • FET 209.6M
  • ADAP 212.3M
  • IPO Year
  • FET 2012
  • ADAP 2015
  • Fundamental
  • Price
  • FET $14.90
  • ADAP $0.64
  • Analyst Decision
  • FET
  • ADAP Strong Buy
  • Analyst Count
  • FET 0
  • ADAP 4
  • Target Price
  • FET N/A
  • ADAP $3.16
  • AVG Volume (30 Days)
  • FET 49.3K
  • ADAP 2.4M
  • Earning Date
  • FET 10-31-2024
  • ADAP 11-13-2024
  • Dividend Yield
  • FET N/A
  • ADAP N/A
  • EPS Growth
  • FET N/A
  • ADAP N/A
  • EPS
  • FET N/A
  • ADAP N/A
  • Revenue
  • FET $800,612,000.00
  • ADAP $175,041,000.00
  • Revenue This Year
  • FET $12.53
  • ADAP $180.15
  • Revenue Next Year
  • FET $1.54
  • ADAP N/A
  • P/E Ratio
  • FET N/A
  • ADAP N/A
  • Revenue Growth
  • FET 7.56
  • ADAP 146.27
  • 52 Week Low
  • FET $12.83
  • ADAP $0.42
  • 52 Week High
  • FET $23.82
  • ADAP $2.05
  • Technical
  • Relative Strength Index (RSI)
  • FET 46.65
  • ADAP 36.20
  • Support Level
  • FET $14.25
  • ADAP $0.57
  • Resistance Level
  • FET $15.50
  • ADAP $0.71
  • Average True Range (ATR)
  • FET 0.54
  • ADAP 0.07
  • MACD
  • FET -0.02
  • ADAP -0.01
  • Stochastic Oscillator
  • FET 36.88
  • ADAP 22.70

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in three reporting segments, namely drilling and downhole which is also its key revenue generating segment, completions, and production. Revenue largely comes from consumable products and activity-based equipment. Consumable products include valves, centrifugal pumps, mud pump fluid end components, rig sensors among others.

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

Share on Social Networks: